在心律失常症中免疫反应的治疗调节
Stephen P Chelko1, Angeliki Asimaki2, Justin Lowenthal3
1Departments of Medicine (S.P.C., D.B., N.A.-A., P.A.), Johns Hopkins School of Medicine, Baltimore, MD.
Circulation
|September 20, 2019
概括
在心律失常症 (ACM) 中,炎症起着关键作用. 抑制核因子-κB信号减少了ACM特征,并可能为这种疾病提供一种新的治疗方法.
科学领域:
- 心血管研究
- 分子生物学
- 免疫学
背景情况:
- 炎症是心律失常症 (ACM) 的已知特征.
- 炎症对ACM疾病表型的具体贡献尚不清楚.
研究的目的:
- 研究核因子-κB (NF-κB) 信号在ACM病变中的作用.
- 评估在ACM中准NF-κB信号的治疗潜力.
主要方法:
- 在体外和体内ACM模型中表征NF- kB信号激活.
- 使用患者衍生的诱导多能干细胞 (iPSC) 心脏肌细胞.
- 用 Bay 11- 7082,一个特定的 NF- kB 抑制剂,以评估其对ACM特征的影响.
主要成果:
- 在体外和体内ACM模型以及患者心肌细胞中激活了NF- kB信号.
- 通过Bay 11- 7082抑制NF- kB信号,改善了ACM的关键特征,包括肌细胞亡,细胞因子释放,心脏功能障碍和纤维化.
- 在接受治疗的小鼠心脏和患者细胞中观察到炎症性细胞因子和化学因子水平的降低.
结论:
- 激活的炎症信号,特别是通过NF-κB,是ACM病变的组成部分.
- 针对炎症途径是一个有前途的,基于机制的治疗策略.
相关概念视频
Myocarditis III: Medical Management
179
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
179
Cardiomyopathy IV: Restrictive Cardiomyopathy
478
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
478
Cardiomyopathy II: Dilated Cardiomyopathy
482
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
482
Cardiomyopathy V: Interprofessional Care
347
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
347
Heart Failure Drugs: Inotropic Agents
1.3K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.3K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.4K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K


